Clinical trial · Observational
Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Management of Patients Followed for Cancer
Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Care of Patients Followed in Oncology for Cancer Within a Mobile Palliative Care Support Team (EMASP)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients having the following gestures (blood test, change of dressing for cancerous lesion and complete toilet in bed) will be identified by the team of the medical oncology department. During the first contact (V0), the study will be presented to the patients in order to obtain their consent. Anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.1). The gesture will then be performed and the patient's comfort will be evaluated after the gesture is performed in order to obtain the starting data for the study. Patients will be reviewed in consultation according to the time recommended for each type of gesture. During the second contact V1 (between 1 and 9 days after D0) anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.2). Patients will then be randomized. After randomization, the first hypnosis session will be performed at the same time as gesture No. 2 and the patient's comfort will be evaluated after the gesture is performed. The patient will receive the self-hypnosis training on the same day. A period of 7 ± 2 days will be considered for the learning time of self-hypnosis. The third contact will take place on day D7+/-2 after V1. During this visit, anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.3). Gesture No.3 will be carried out under the effect of self-hypnosis ± aromatherapy and the measurement of comfort will be carried out immediately afterwards
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hypnosis | Other | — | UNRESOLVED |
| Hypnosis with aromatherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- hypnosis
- description
- patients in the hypnosis group will perform self-hypnosis sessions
- interventionNames
- Other: hypnosis
- label
- hypnosis with aromatherapy
- description
- patients in the hypnosis with aromatherapy group will perform self-hypnosis sessions with inhalation of an essential oil
- interventionNames
- Other: Hypnosis with aromatherapy
Primary outcomes (1)
- measure
- difference in comfort score between the two groups: The comfort score will be evaluated by the French version of the pain scale of the Edmonton Symptom Assessment System
- timeFrame
- betwen the baseline and day 17
- description
- The comfort score will be evaluated by the French version of the pain scale of the Edmonton Symptom Assessment System. The severity of each symptom was rated from 0 to 10 (0 = no symptom, 10 = worst possible intensity
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged ≥18 years * Patients followed in medical oncology and by the mobile palliative care support team * From the first line of chemotherapy * Patient requiring one of the following procedures: * Blood samples via a central catheter with a percutaneous implantable chamber, with a Huber needle * Peripheral venous samples * Change of dressing for cancerous lesion * Complete toilet in bed * Patients who have given their consent * Patient affiliated with a social security scheme Exclusion Criteria: * Protected person under guardianship or curatorship, * Person deprived of liberty * Person unable to express consent * Pregnant woman and breastfeeding woman * History of allergy or intolerance to essential oils * Patients with cognitive or language disorders that make it impossible to answer the questionnaires * Psychotic disorders
References
Publications (0)
Data not yet available